Global Biomarker Market Analysis 2017: Industry Demand, Trends, Type, Application and Forecast 2024
Global Biomarkers Market By Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), By Product Type (Consumables, Services, Software), Technology (Safety Biomarkers, Efficacy Biomarker
(EMAILWIRE.COM, February 06, 2018 ) Global Biomarker Market is expected to reach USD 85,927.95 million by 2024 from USD 28,091.78 million in 2016, at a CAGR of 15.1%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The global biomarker market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. The global biomarker market is dominated by Bio-Rad Laboratories, Inc., followed by PerkinElmer, Inc. and Qiagen. Other players in this market include Merck & Co., Inc., EKF Diagnostics, Enzo biochem, Inc., Meso Scale Diagnostics, LLC, Singulex, Inc., Signosis, Inc., and Cisbio Bioassays among others holds 32.0% of the global biomarker market in 2016.
Request For Free Sample Copy @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market
BIO-RAD LABORATORIES INC.:
Founded in 1952 and headquartered in California, U.S. Bio-Rad laboratories, Inc. develops and commercializes the wide range of products and systems in the healthcare, life science research, analytical chemistry and few other areas, which is used for the separation of composite chemical and biological ingredients and for the analysis and purification of their components. Bio-Rad operates its business in two industry segments named as life science and clinical diagnostics. Clinical Diagnostics segment manufactures, commercializes informatics systems, test systems, test kits and quality controls for the clinical laboratories.
Bio-rad has its presence across the globe in United States, Australia, Greece, Portugal, Austria, Hong Kong, Russia, Belgium, France, Hungary, South Africa, Singapore, Brazil, India, Canada, Israel, South Korea, China, Italy, Spain, Czech Republic, Japan, Sweden, Denmark, Netherlands, Mexico, Switzerland, Egypt, Taiwan, Finland, New Zealand, Thailand, Norway, United Kingdom, Germany, and Poland.
Inquire before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biomarkers-market
PERKINELMER INC.:
Incorporated in 1947 and headquartered in Massachusetts, U.S. PerkinElmer, Inc. is a supplier and manufacturer of products, services and solutions for the food, diagnostics, industrial, environmental, life sciences research and laboratory services markets. The company operates its business through two business segments which includes discovery & analytical solutions and diagnostics. The diagnostics segment provides products and wide range of reagents, instruments, assay platforms, and software for hospitals, medical labs, clinicians, and medical research professionals. The segment focusses on the areas such as reproductive health, developing market diagnostics, and applied genomics.
PerkinElmer develops, manufactures and markets a broad range of branded, generic and branded generic pharmaceutical products which are marketed directly or indirectly in U.S. and across the globe. The company commercializes products and services in over 150 countries.
QIAGEN:-
Founded in 1984 and headquartered at Hilden, Germany, Qiagen is engaged in sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company operates through different business segments, namely Next-Gen Sequencing, Molecular Diagnostic, Life Sconce Research, Animal and Vet. Testing, Bioinformatics and others. The molecular diagnostic segment includes Oncology, Infectious Disease, Tuberculosis Management, Transplantation Testing and Women’s health. Next-Gen Sequencing covers GeneReader NGS System and QIAseq NGS Solutions.
Qiagen has its operations across the North America, Europe, Middle East and Africa, Asia-Pacific and rest of world. Some of its subsidiaries include Exiqon (Denmark), Cellestis (Australia), Tiangen Biotech Co. Ltd. (Beijing), Qiagen Ltd. (India), Ipsogen SA (France) and many more subsidiaries across the globe.
Access Full Report @ http://databridgemarketresearch.com/reports/global-biomarkers-market/
TABLE OF CONTENTS
1. INTRODUCTION
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Global Biomarkers Market
2. MARKET SEGMENTATION
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
3. MARKET OVERVIEW
3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Challenges
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. BIOMARKERS MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Consumables,
6.3. Services,
7. BIOMARKERS MARKET, BY TECHNOLOGY
7.1. Overview
7.2. Safety Biomarkers
7.3. Efficacy Biomarkers
8. BIOMARKERS MARKET, BY APPLICATION
8.1. Overview
8.2. Diagnostics Development
8.3. Drug Discovery And Development
9. BIOMARKERS MARKET, BY INDICATION
9.1. Overview
9.2. Cancer
9.3. Cardiovascular Disorders
10. BIOMARKERS MARKET, BY GEOGRAPHY
10.1.1. North America
10.1.2. Europe
10.1.3. Asia-Pacific (Apac)
11. BIOMARKERS MARKET: COMPETITIVE LANDSCAPE
11.1. Global Biomarkers Market: Company Share Analysis
11.2. U.S. Biomarkers Market: Company Share Analysis
11.3. Europe Biomarkers Market: Company Share Analysis
12. BIOMARKERS MARKET, COMPANY PROFILES
12.1. Qiagen N.V
12.2. Perkinelmer, Inc
12.3. Merck & Co, Inc.
12.4. Bio-Rad Laboratories
12.5. Enzo Biochem, Inc.,
12.6. Ekf Diagnostics Holdings, Plc
12.7. Meso Scale Diagnostics
12.8. Llc, Singulex, Inc.,
12.9. Cisbio Bioassays
12.10. Biosims Technologies
More Information and Related Reports are:
Europe Biomarkers Market – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/europe-biomarkers-market/
The Europe Biomarker Market is expected to reach USD 21,478.87 million by 2024, from USD 6,910.58 million in 2016 growing at a CAGR of 15.3% in the forecast period 2017 to 2024.
Asia-Pacific (APAC) Biomarkers Market – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/asia-pacific-biomarkers-market/
The Asia-Pacific Biomarker Market is expected to reach USD 16,388.98 million by 2024, from USD 5,168.89 million in 2016 growing at a CAGR of 15.6% in the forecast period 2017 to 2024.
North America Biomarkers Market – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/north-america-biomarkers-market/
The North America Biomarker Market is expected to reach USD 36,827.75 million by 2024, from USD 12,163.74 million in 2016 growing at a CAGR of 15.0% in the forecast period 2017 to 2024.
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
The global biomarker market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. The global biomarker market is dominated by Bio-Rad Laboratories, Inc., followed by PerkinElmer, Inc. and Qiagen. Other players in this market include Merck & Co., Inc., EKF Diagnostics, Enzo biochem, Inc., Meso Scale Diagnostics, LLC, Singulex, Inc., Signosis, Inc., and Cisbio Bioassays among others holds 32.0% of the global biomarker market in 2016.
Request For Free Sample Copy @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market
BIO-RAD LABORATORIES INC.:
Founded in 1952 and headquartered in California, U.S. Bio-Rad laboratories, Inc. develops and commercializes the wide range of products and systems in the healthcare, life science research, analytical chemistry and few other areas, which is used for the separation of composite chemical and biological ingredients and for the analysis and purification of their components. Bio-Rad operates its business in two industry segments named as life science and clinical diagnostics. Clinical Diagnostics segment manufactures, commercializes informatics systems, test systems, test kits and quality controls for the clinical laboratories.
Bio-rad has its presence across the globe in United States, Australia, Greece, Portugal, Austria, Hong Kong, Russia, Belgium, France, Hungary, South Africa, Singapore, Brazil, India, Canada, Israel, South Korea, China, Italy, Spain, Czech Republic, Japan, Sweden, Denmark, Netherlands, Mexico, Switzerland, Egypt, Taiwan, Finland, New Zealand, Thailand, Norway, United Kingdom, Germany, and Poland.
Inquire before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biomarkers-market
PERKINELMER INC.:
Incorporated in 1947 and headquartered in Massachusetts, U.S. PerkinElmer, Inc. is a supplier and manufacturer of products, services and solutions for the food, diagnostics, industrial, environmental, life sciences research and laboratory services markets. The company operates its business through two business segments which includes discovery & analytical solutions and diagnostics. The diagnostics segment provides products and wide range of reagents, instruments, assay platforms, and software for hospitals, medical labs, clinicians, and medical research professionals. The segment focusses on the areas such as reproductive health, developing market diagnostics, and applied genomics.
PerkinElmer develops, manufactures and markets a broad range of branded, generic and branded generic pharmaceutical products which are marketed directly or indirectly in U.S. and across the globe. The company commercializes products and services in over 150 countries.
QIAGEN:-
Founded in 1984 and headquartered at Hilden, Germany, Qiagen is engaged in sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company operates through different business segments, namely Next-Gen Sequencing, Molecular Diagnostic, Life Sconce Research, Animal and Vet. Testing, Bioinformatics and others. The molecular diagnostic segment includes Oncology, Infectious Disease, Tuberculosis Management, Transplantation Testing and Women’s health. Next-Gen Sequencing covers GeneReader NGS System and QIAseq NGS Solutions.
Qiagen has its operations across the North America, Europe, Middle East and Africa, Asia-Pacific and rest of world. Some of its subsidiaries include Exiqon (Denmark), Cellestis (Australia), Tiangen Biotech Co. Ltd. (Beijing), Qiagen Ltd. (India), Ipsogen SA (France) and many more subsidiaries across the globe.
Access Full Report @ http://databridgemarketresearch.com/reports/global-biomarkers-market/
TABLE OF CONTENTS
1. INTRODUCTION
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Global Biomarkers Market
2. MARKET SEGMENTATION
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
3. MARKET OVERVIEW
3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Challenges
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. BIOMARKERS MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Consumables,
6.3. Services,
7. BIOMARKERS MARKET, BY TECHNOLOGY
7.1. Overview
7.2. Safety Biomarkers
7.3. Efficacy Biomarkers
8. BIOMARKERS MARKET, BY APPLICATION
8.1. Overview
8.2. Diagnostics Development
8.3. Drug Discovery And Development
9. BIOMARKERS MARKET, BY INDICATION
9.1. Overview
9.2. Cancer
9.3. Cardiovascular Disorders
10. BIOMARKERS MARKET, BY GEOGRAPHY
10.1.1. North America
10.1.2. Europe
10.1.3. Asia-Pacific (Apac)
11. BIOMARKERS MARKET: COMPETITIVE LANDSCAPE
11.1. Global Biomarkers Market: Company Share Analysis
11.2. U.S. Biomarkers Market: Company Share Analysis
11.3. Europe Biomarkers Market: Company Share Analysis
12. BIOMARKERS MARKET, COMPANY PROFILES
12.1. Qiagen N.V
12.2. Perkinelmer, Inc
12.3. Merck & Co, Inc.
12.4. Bio-Rad Laboratories
12.5. Enzo Biochem, Inc.,
12.6. Ekf Diagnostics Holdings, Plc
12.7. Meso Scale Diagnostics
12.8. Llc, Singulex, Inc.,
12.9. Cisbio Bioassays
12.10. Biosims Technologies
More Information and Related Reports are:
Europe Biomarkers Market – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/europe-biomarkers-market/
The Europe Biomarker Market is expected to reach USD 21,478.87 million by 2024, from USD 6,910.58 million in 2016 growing at a CAGR of 15.3% in the forecast period 2017 to 2024.
Asia-Pacific (APAC) Biomarkers Market – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/asia-pacific-biomarkers-market/
The Asia-Pacific Biomarker Market is expected to reach USD 16,388.98 million by 2024, from USD 5,168.89 million in 2016 growing at a CAGR of 15.6% in the forecast period 2017 to 2024.
North America Biomarkers Market – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/north-america-biomarkers-market/
The North America Biomarker Market is expected to reach USD 36,827.75 million by 2024, from USD 12,163.74 million in 2016 growing at a CAGR of 15.0% in the forecast period 2017 to 2024.
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Information:
Data Bridge Market Research
Data Bridge Market Resea
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Data Bridge Market Research
Data Bridge Market Resea
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results